The hippocampus is a critical structure for encoding of novel experiences. A particularly compelling puzzle is how the hippocampus encodes new information in the presence of interference from past memories. … Continue Reading Neuroimaging shows how the brain switches from past to present memory mode.
NMDA glutamate receptors function as receptors which bond with glutamates, and are known to be deeply involved in memory and learning. In order for memories to be created inside the … Continue Reading Study identifies microtubule protein crucial for synaptic plasticity and memory.
In the brain, patterns of neural activity are perfectly balanced. The interplay between activating and inhibitory neurotransmitters ensures that the level of activity stays within the physiological range. Neuronal degeneration … Continue Reading Researchers begin to map neuroprotective pathway after epileptic seizure.
Glutamate is an amino acid with very different functions. In the pancreas, it modulates the activity of the pancreatic ß-cells responsible for insulin production, whereas in the brain it is … Continue Reading Study verifies long-standing hypothesis that glutamate is brain’s energy-source.
Epilepsy is a very prevalent neurological disorder. Approximately one-third of patients are resistant to currently available therapies. A team of researchers from the University of Bonn has discovered a new … Continue Reading Astrocytic ‘uncoupling’ identified and reversed in temporal lobe epilepsy.
Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop. Immune abnormalities in patients … Continue Reading Study identifies psychosis as a quantifiable neurological autoimmune disease.
Scientists at the Centre for Addiction and Mental Health (CAMH) and the University of Toronto have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they’ve … Continue Reading New target identified in the spinal cord for multiple sclerosis.
Drugs that boost the function of a specific type of neurotransmitter receptor may provide benefit to patients with the second most common type of dementia, according to research by scientists … Continue Reading Scientists boost receptor-function to treat Frontotemporal dementia.
Researchers at University of California have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as ‘disappointment.’ The discovery of … Continue Reading Scientists discover ‘dimmer switch’ for mood disorders.